Physician profile
Christopher Dwyer
NPI 1538456561
$5,108.04
in general payments reported to CMS, 2019-2025
21 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,016 · 2020: $210 · 2021: $790 · 2022: $815 · 2023: $16.50 · 2024: $465 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876 · Travel and Lodging: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.62 |
| Travel and Lodging | $401.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,090.44 | 2019-2025 | |
| Stryker Corporation | $1,573.07 | 2019-2025 | 1788 |
| Medtronic, INC. | $407.77 | 2022 | |
| Axonics, INC. | $251.82 | 2024 | Axonics |
| Dilon Technologies, INC. | $163.48 | 2024 | Hemoblast Bellows |
| Sirtex Medical INC | $116.34 | 2019 | |
| Abbvie INC. | $100.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.76 | 2021-2024 | Gattex |
| Thd America, INC. | $65.77 | 2020-2023 | |
| Tela Bio, INC. | $47.20 | 2019-2024 | Ovitex 2s |
| Conmed Corporation | $45.45 | 2019 | |
| Activ Surgical, INC. | $30.23 | 2022 | |
| Amphastar Pharmaceuticals, INC. | $23.45 | 2025 | |
| Palette Life Sciences, INC. | $19.45 | 2022 | |
| Medtronic USA, INC. | $17.31 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $17.17 | 2019 | |
| Shire North American Group INC | $15.51 | 2019 | |
| Zyla Life Sciences, INC. | $15.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.22 | 2019 | |
| Braintree Laboratories, INC. | $13.53 | 2022 | |
| Boston Scientific Corporation | $10.83 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dwyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.